Masakazu Atobe

Dr. Masakazu Atobe

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
TDThomas D. Downes
Thomas D. Downes
SJS. Paul Jones
S. Paul Jones
HKHanna F. Klein
Hanna F. Klein
MWMary C. Wheldon
Mary C. Wheldon
MAMasakazu Atobe
Masakazu Atobe
POPeter O'Brien
Peter O'Brien
Fragment‐based drug discovery is now widely adopted for lead generation in the pharmaceutical industry. However, fragment screening collections are often predominantly populated with flat, 2D molecules. Herein, we describe a workflow for the design and synthesis of 56 3D disubstituted pyrrolidine and piperidine fragments that occupy under‐represented areas of fragment space (as demonstrated by a principal moments of inertia (PMI) analysis). A key, and unique, underpinning design feature of this fragment collection is that assessment of fragment shape and conformational diversity (by considering conformations up to 1.5 kcal mol−1 above the energy of the global minimum energy conformer) is carried out prior to synthesis and is also used to select targets for synthesis. The 3D fragments were designed to contain suitable synthetic handles for future fragment elaboration. Finally, by comparing our 3D fragments with six commercial libraries, it is clear that our collection has high three‐dimensionality and shape diversity.


10 January 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMasakazu Atobe
Masakazu Atobe
TNTakamichi Nagami
Takamichi Nagami
SMShuji Muramatsu
Shuji Muramatsu
TOTakeshi Ohno
Takeshi Ohno
MKMasayuki Kitagawa
Masayuki Kitagawa
MKMasashi Kawanishi
Masashi Kawanishi


27 September 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
JDJohn F. Darby
John F. Darby
MAMasakazu Atobe
Masakazu Atobe
JFJames D. Firth
James D. Firth
PBPaul Bond
Paul Bond
GDGideon J. Davies
Gideon J. Davies
RHRoderick E. Hubbard
Roderick E. Hubbard
Modulation of enzyme activity is a powerful means of probing cellular function and can be exploited for diverse applications. Here, we explore a method of enzyme activation where covalent tethering of a small molecule to an enzyme can increase catalytic activity (kcat/KM) up to 35-fold. Using a bacterial glycoside hydrolase, BtGH84, we demonstrate how small molecule “fragments”, identified as activators in free solution, can be covalently tethered to the protein using Michael-addition chemistry. We show how tethering generates a constitutively-activated enzyme-fragment conjugate, which displays both improved catalytic efficiency and increased susceptibility to certain inhibitor classes. Structure guided modifications of the tethered fragment demonstrate how specific interactions between the fragment and the enzyme influence the extent of activation. This work suggests that a similar approach may be used to modulate the activity of enzymes such as to improve catalytic efficiency or increase inhibitor susceptibility.

1 October 2002 in Tetrahedron Letters
Verified
Journal Article
Closed access
NYNaoki Yamazaki
Naoki Yamazaki
MAMasakazu Atobe
Masakazu Atobe
CKChihiro Kibayashi
Chihiro Kibayashi